Major AI executives and biotech experts are lobbying Congress to tighten screening and record-keeping for companies that sell synthetic DNA/RNA. The argument is that AI could make it easier for bad actors to design risky biological sequences. While policy discussions around AI-enabled biotech are still in their early stages, firms within the field are moving fast. In recent months, Neuralink publicly claimed to have 20 “Telepathy” patients who can control computers with thought alone. The head of Google’s frontier AI lab, meanwhile, predicted all diseases could be cured within the next “decade or so.”

An unusually broad coalition of companies and governments completed disruption of a Southeast Asia-based scam ecosystem this week. Led by a Department of Justice strike force, tech giants including Meta and Microsoft shared intelligence that led to dozens of arrests and over 1 million social media accounts being disabled. The operation also extended into satellite internet technology and cryptocurrency, showing how modern enforcement is sharpening alongside the malicious operations it confronts.

Microsoft is the latest in a string of major AI providers switching up their pricing model. (Business Insider)

Future computer malware could adapt its attack strategy machine-by-machine, researchers say. (University of Toronto / paper)

Litigants in Florida will soon have to follow a fresh statewide rule to reduce legal filings with hallucinated support. (The Florida Bar)

A new kind of online-age law has Apple verifying the age of new account holders in Texas. (Texas Tribune)